About this trial
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV.
Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma?
Participants will:
* download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
HIV+
Identifies as either a racial, ethnic, sexual or gender minority or a cisgender female and
Newly diagnosed within last 12 months
Out of care (greater than 6 months between any two HIV provider visits in last 24 months)
Disqualifiers
prior use of Positive Peers mobile app
Trial design
Parallel
Treatments tested in this trial
Positive Peers mobile app
Other interventionPositive Peers is a multifunctional mobile app using a mind, body, spirit theme aimed to improve HIV care outcomes.
Treatment groups
Trial outcomes
Primary outcomes
Viral suppression
Proportion of participants who have HIV viral load \<200 copies/ ml
Secondary outcomes
Correlates of app use and viral suppression
Identify participant demographic and psychosocial factors from the baseline survey that correlate with app use and viral suppression (viral load \< 200 copies/ ml).
Correlates of app use and retention in care
Identify participant demographic and psychosocial factors from the baseline survey that correlate with app use on retention in care (completing office visit at least every 6 months)
Correlates of app use and HIV related perceived stigma
Identify participant demographic and psychosocial factors from the baseline survey that correlate with app use and changes in HIV-related perceived stigma on the HIV Stigma scale (Eriksson).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
MetroHealth Medical Center
Lead sponsor
Kent State University
Collaborator